What is it about?
No to do harm is an important guide for MDs in treating pain patients. Not to do harm is possible with analgeiscs like the body-own molecule palmitoylethanolamide. Since 2015 we know its NNT in neuropathic pain: 1.5. Thus each pain specialist should start treatment of pain with palmitoylethanolamide (3 times 400 mg/day).
Featured Image
Why is it important?
This is important while there ar too many patients with low analgesics compliance. PEA can changes this.
Perspectives
I think MDs should start triggering body-own mechanisms to counteract pain, such as with palmitoylethanooamide. Its proven efficacy (NNT 1.5) and absence of troublesome side effects nearly dictates to give this compound a central place in analgesia.
jan keppel hesselink
Institute Neuropathic Pain
Read the Original
This page is a summary of: Primumnon Nocere: Supplements As Analgesics, A Neglected Area, Journal of Pain & Relief, January 2013, OMICS Publishing Group,
DOI: 10.4172/2167-0846.1000e116.
You can read the full text:
Contributors
The following have contributed to this page
